Saudi Arabia Veterinary Pharma Market - Strategic Insights and Forecasts (2026-2031)
Market Size, Share, Forecasts & Trends Analysis By Product Type (Injectable, Oral, Topical, Auricular, Ophthalmic, and Nasal), By Animal Type (Companion Animal, Production Animal), By End User (Vet Hospitals and Clinics, Animal Farms, Others), and Geography
Tell us your specific requirements and we will customize this report for you.
Navigate-
Frequently Asked Questions
The Saudi Arabia Veterinary Pharmaceuticals Market is forecast to grow at a Compound Annual Growth Rate (CAGR) of 6.62%. This growth is expected to lead the market to reach USD 53.87 million in 2031, up from USD 38.96 million in 2026, according to the report's strategic insights.
Key drivers include rising pet ownership boosting demand for preventive care and pharmaceuticals, rapidly expanding poultry production increasing vaccine and antibiotic usage, and the growing number of veterinary hospitals and clinics enhancing access to advanced treatments. Furthermore, government policies supporting livestock health are significantly contributing to market growth.
Government policies actively support livestock health, which fuels market expansion. For instance, the Ministry of Environment, Water, and Agriculture announced 275 new licenses in the poultry production and breeding sector, including projects for broilers, egg production, and broiler mother breeding, directly increasing the demand for veterinary vaccines and related products.
Saudi Arabia's increasing demand for dairy and meat, driven by the country's need for protein, is fueling animal production. This trend, particularly in poultry farming, directly increases the demand for veterinary vaccines and antibiotics to maintain animal health, as highlighted by the significant number of new poultry production licenses issued.
Preventive care, encompassing vaccinations, parasite control, and wellness examinations, is an essential component. The increasing importance of pets in Saudi households has heightened demand for pet medicine and vaccinations. Additionally, concerns about zoonotic diseases are driving greater attention to animal health, including widespread vaccination and effective disease control strategies.
Both the pet care and livestock segments are significant contributors. Rising pet ownership is directly boosting demand for pet-related pharmaceuticals and preventive care. Concurrently, the rapidly expanding poultry production and overall increased animal consumption indicators are driving substantial usage of vaccines and antibiotics for livestock.
